1Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J].Cell,1997;89(2):309-19.
2Kostenuik PJ.Osteoprotegerin and RANKL regulate bone resorption,density,geometry and strength[J].Curr,Opin,Pharmacol,2005;5(6):618-25.
3Asanuma Y,Chung CP,Oeser A,et al.Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis[J].Atherosclerosis,2007;195(2):135-41.
4Middleton S,Bolon B.Additive bone-protective effects of anabolic treatmet when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models[J].Arthritis Rheum,2005;52(5),1604-11.
5Mezquita-Raya,P,de la Higuera,M,Garcia,DF,et al.The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women[J].Osteoporosis Int,2005;16(11):1368-74.
6Janssens K,de Vernejoul MC,de Freitas F,et al.An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation[J].Bone,2005;36(3):542-8.
7Arenillas JF,Alvarez-Sabin J.Basic mechanisms in intracranial large-artery atherosclerosis:advances and challenges[J].Cerebrovasc Dis,2005;20(2):75-83.
8Rhee EJ,Lee WY,Kim SY,et al.Relation ship of serum osteoprotegerin levels with coronary artery disease severity,left ventricular hypertrophy and C-reactive protein.Clin Sci (London),2005;108(3):237-243.
9Corey E,Brown LG,Kiefer JA,et al.Osteoprotegerin in prostate cancer bone metastasis[J].Cancer Res,2005;65(5):1710-8.
10American Society for Bone and Mineral Research President's Committee on Nomenclature.Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption.The American Society for Bone and Mineral Research President's Committee on Nomenclature[J].J Bone Miner Res,2000;15(12):2293-6.
3Yasuda H. Bone and bone related biochemical examinations.Bone and collagen related metabolities.Receptor activator ofNF-kappaB ligand(RANNKL) [J].Clin Calcium, 2006, 16(6):964.
4Coxam V. Phyto-ostrogens and bone health[J].Proc Nutr Soc,2008,67(2):184.
5Fahrleitner-Pammer A, Dobnig H, Piswanger-Soelkner C, etal. Osteoprotegerin serum levels in women: correlation withage, bone mass,bone tunover and fractures status[J].WienKlin Wochenshr, 2003, 115(9):291.
6West SL, Scheid JL, De Souza MJ. The effect of exerciseand estrogen on osteoprotegerin in premenopausal women[J].Bone, 2009, 44(1): 137.
